Purchase Order N3239825P0128
- Not listed
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $20,297.72 firm fixed-price delivery order by the Bureau of Medicine and Surgery (an element of the Department of Defense) on February 11, 2020, with an ultimate completion date of February 18, 2021. The contract covers service maintenance on a BD FACSCanto II flow cytometer (serial number V96101183), a sophisticated instrument used for cell analysis and research applications. The work will be...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order maintenance contract valued at $133,256 with an ultimate completion date of October 31, 2005. This firm fixed-price contract, awarded on December 13, 2004, was issued without a set-aside designation and calls for performance in Rockville, Maryland. As a child contract under BD's parent entity, this delivery order reflects BD's established role as a primary supplier of sophisticated...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract valued at $11,385.00 by a federal agency for maintenance services on a FACScan flow cytometry instrument (Serial Number 81449). The contract was awarded on October 1, 2006, with an ultimate completion date of September 30, 2007, and will be performed in Bethesda, Maryland. This award was made on a full and open competition basis without small business set-aside...
- The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a $47,886.84 firm fixed-price purchase order contract to Becton, Dickinson and Company (BD) to provide maintenance services for a BD LSRFortessa flow cytometry instrument and associated equipment. The contract has a period of performance from September 27, 2024 to September 26, 2025, with two scheduled preventive maintenance visits per year. This sole-source award is not set aside and is being procured under FAR...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order contract on October 1, 2006, for maintenance services on a FACSORT 5-day flow cytometry system. The contract, valued at $13,425 and set to conclude on September 30, 2007, is a child delivery order under a larger indefinite delivery vehicle and represents continuation of technical support for sophisticated laboratory instrumentation. The work will be performed at the Bethesda,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order contract valued at $11,385.00 for a five-day maintenance agreement on a FACScan instrument system, with performance in Bethesda, Maryland. The contract was awarded on October 1, 2006, with an ultimate completion date of September 30, 2007. This delivery order was issued without a small business set-aside designation, reflecting BD's established competitive position in providing...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract on October 17, 2006, for maintenance services on FACS-CAL IBUR 4 Color flow cytometry equipment with a five-day service week. The contract, valued at approximately $21.4K with an ultimate completion date of September 30, 2007, was awarded without a small business set-aside designation. The place of performance is located in Bethesda, Maryland, which aligns with the...
- Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, was awarded a $22,248.36 firm fixed price BPA (Blanket Purchase Agreement) call by the National Institute of Arthritis and Musculoskeletal and Skin Diseases for maintenance services on a FACSymphony A3 flow cytometry instrument. The award, issued on December 15, 2024, with an ultimate completion date of June 14, 2025, represents a call against an existing BPA vehicle and includes no small business set-aside...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $21,578.76 Firm Fixed Price Blanket Purchase Agreement (BPA) call for maintenance services on a FACSymphony A3 flow cytometry instrument by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract, awarded on June 15, 2024, with an ultimate completion date of December 14, 2024, will be performed at the...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order contract on October 1, 2003, for maintenance services on a FACS Vantage SE flow cytometry instrument (Serial #SE0274). This firm fixed-price contract, valued at $38,628, is scheduled for completion by September 30, 2004, and will be performed in Maryland. The contract was awarded on a full and open competitive basis without a small business set-aside designation, consistent with...
Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a maintenance services contract by the Bureau of Medicine and Surgery (BUMED) for FACSymphony Instruments on November 1, 2025. The contract, issued as a purchase order with firm fixed pricing, covers maintenance services for two instrument systems: a FACSymphony A1 and a FACS Flow Supply System. The contract carries a ceiling value of $88,457.40 and includes a base period plus four option years, with an ultimate completion date of October 31, 2030. No small business set-aside was utilized for this award, and performance will occur in Silver Spring, Maryland. BD Biosciences is a leading provider of flow cytometry instruments and maintenance services to federal healthcare and research institutions, with an extensive portfolio of contracts across the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and other Defense Department components. This maintenance contract supports BUMED's operational requirements for critical flow cytometry instrumentation used in medical research and clinical diagnostics across the Defense medical research enterprise. The award reflects BD's established competitive position and demonstrated capabilities in delivering specialized instrument maintenance and technical support services to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 9/29/25 |